These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31617178)

  • 1. CRISPR/Cas9-Based Genome Editing of HSV.
    Velusamy T; Gowripalan A; Tscharke DC
    Methods Mol Biol; 2020; 2060():169-183. PubMed ID: 31617178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput engineering of cytoplasmic- and nuclear-replicating large dsDNA viruses by CRISPR/Cas9.
    López-Muñoz AD; Rastrojo A; Martín R; Alcami A
    J Gen Virol; 2022 Oct; 103(10):. PubMed ID: 36260063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recruitment of DNA Repair MRN Complex by Intrinsically Disordered Protein Domain Fused to Cas9 Improves Efficiency of CRISPR-Mediated Genome Editing.
    Reuven N; Adler J; Broennimann K; Myers N; Shaul Y
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31597252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing the Efficiency of CRISPR/Cas9-mediated Precise Genome Editing of HSV-1 Virus in Human Cells.
    Lin C; Li H; Hao M; Xiong D; Luo Y; Huang C; Yuan Q; Zhang J; Xia N
    Sci Rep; 2016 Oct; 6():34531. PubMed ID: 27713537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research.
    Wang D; Wang XW; Peng XC; Xiang Y; Song SB; Wang YY; Chen L; Xin VW; Lyu YN; Ji J; Ma ZW; Li CB; Xin HW
    Cancer Gene Ther; 2018 Jun; 25(5-6):93-105. PubMed ID: 29691470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Genome Editing Approaches against Herpes Simplex Virus Infections.
    Zhang I; Hsiao Z; Liu F
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33671590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR/Cas9.
    Oh HS; Neuhausser WM; Eggan P; Angelova M; Kirchner R; Eggan KC; Knipe DM
    Elife; 2019 Dec; 8():. PubMed ID: 31789594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections.
    Chen YC; Sheng J; Trang P; Liu F
    Viruses; 2018 May; 10(6):. PubMed ID: 29844277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A knockdown of the herpes simplex virus type-1 gene in all-in-one CRISPR vectors.
    Khodadad N; Fani M; Jamehdor S; Nahidsamiei R; Makvandi M; Kaboli S; Teimoori A; Thekkiniath J
    Folia Histochem Cytobiol; 2020; 58(3):174-181. PubMed ID: 32937678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and Optimization of Herpes Simplex Virus Vectors for Central Nervous System Gene Delivery based on CRISPR/Cas9-mediated Genome Editing.
    Huang X; Li X; Yang L; Wang P; Yan J; Nie Z; Gao Y; Li Z; Wen J; Cao X
    Curr Gene Ther; 2022; 22(1):66-77. PubMed ID: 34148538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.
    van Diemen FR; Kruse EM; Hooykaas MJ; Bruggeling CE; Schürch AC; van Ham PM; Imhof SM; Nijhuis M; Wiertz EJ; Lebbink RJ
    PLoS Pathog; 2016 Jun; 12(6):e1005701. PubMed ID: 27362483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HSV-1 Replication by Gene Editing Strategy.
    Roehm PC; Shekarabi M; Wollebo HS; Bellizzi A; He L; Salkind J; Khalili K
    Sci Rep; 2016 Apr; 6():23146. PubMed ID: 27064617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of baculovirus as protein expression vector and as biopesticide by CRISPR/Cas9 editing.
    Pazmiño-Ibarra V; Mengual-Martí A; Targovnik AM; Herrero S
    Biotechnol Bioeng; 2019 Nov; 116(11):2823-2833. PubMed ID: 31403180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HSV-1 tegument protein and the development of its genome editing technology.
    Xu X; Che Y; Li Q
    Virol J; 2016 Jun; 13():108. PubMed ID: 27343062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a genome editing technique using the CRISPR/Cas9 system in the industrial filamentous fungus Aspergillus oryzae.
    Katayama T; Tanaka Y; Okabe T; Nakamura H; Fujii W; Kitamoto K; Maruyama J
    Biotechnol Lett; 2016 Apr; 38(4):637-42. PubMed ID: 26687199
    [TBL] [